organization · Reporting owner
AFH Holding & Advisory, LLC
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bone Biologics CorpBBLG · Entity 8560 | 10% owner | September 07, 2017 | December 05, 2017 |
| NEONC TECHNOLOGIES HOLDINGS, INC.NTHI · Entity 6646 | 10% owner · Joint Reporting Owner | March 25, 2025 | March 25, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bone Biologics Corp
Report date September 07, 2017 · Filed December 05, 2017
Jointly reported with Heshmatpour Amir F
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy AFH Holding & Advisory LLC | 1,941,579 |
Reported balance
After 2017-09-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-09-07 · Other · Disposed 1,826,779 · Balance 1,941,579 F1: The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC ("AFH Holding") to H&H Funding, LLC ("H&H"). F2: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding. |
| Common StockSEC Table I · non-derivative | IndirectBy H&H Funding, LLC | 1,826,779 |
Reported balance
After 2017-09-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2017-09-07 · Other · Acquired 1,826,779 · Balance 1,826,779 F1: The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC ("AFH Holding") to H&H Funding, LLC ("H&H"). F2: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding. F3: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectBy H&H Funding, LLC | 2,026,779 |
Reported balance
After 2017-09-07 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2017-09-07 · Other · Acquired 200,000 · Balance 2,026,779 F4: The reported shares reflect the transfer of securities held directly by H&H (Hong Kong) Holdings Co, of which Mr. Heshmatpour is the sole stockholder, to H&H. F2: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding. F3: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectBy H&H Funding, LLC | 2,942,393 |
Reported balance
After 2017-11-29 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2017-11-29 · Other · Acquired 915,614 · Balance 2,942,393 F3: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | IndirectBy children | 600,000 |
Reported balance
Holding disclosure · report date 2017-09-07 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 600,000 F5: The reported shares include (i) 600,000 shares owned directly by Mr. Heshmatpour's children, as to which Mr. Heshmatpour disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any; and (ii) 300,000 shares owned directly by KIG LLC, of which the Mr. Heshmatpour's spouse is the sole member and over which she has sole voting and investment control, as to which Mr. Heshmatpour disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | IndirectBy KIG LLC | 300,000 |
Reported balance
Holding disclosure · report date 2017-09-07 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 300,000 F5: The reported shares include (i) 600,000 shares owned directly by Mr. Heshmatpour's children, as to which Mr. Heshmatpour disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any; and (ii) 300,000 shares owned directly by KIG LLC, of which the Mr. Heshmatpour's spouse is the sole member and over which she has sole voting and investment control, as to which Mr. Heshmatpour disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC ("AFH Holding") to H&H Funding, LLC ("H&H").
F2: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding.
F3: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein.
F4: The reported shares reflect the transfer of securities held directly by H&H (Hong Kong) Holdings Co, of which Mr. Heshmatpour is the sole stockholder, to H&H.
F5: The reported shares include (i) 600,000 shares owned directly by Mr. Heshmatpour's children, as to which Mr. Heshmatpour disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any; and (ii) 300,000 shares owned directly by KIG LLC, of which the Mr. Heshmatpour's spouse is the sole member and over which she has sole voting and investment control, as to which Mr. Heshmatpour disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any.
NEONC TECHNOLOGIES HOLDINGS, INC.
Report date March 25, 2025 · Filed March 25, 2025
Jointly reported with Heshmatpour Amir F
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,025,000 |
Reported balance
Holding disclosure · report date 2025-03-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,025,000 F1: Includes (i) 500,000 shares held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership, except to the extent of his pecuniary interest, if any, therein, and (ii) 1,200,000 shares of restricted stock (the "Shares") granted pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest on a date that is seven months after the effective date of Issuer's initial listing. |
| Common StockSEC Table I · non-derivative | IndirectBy AFH Holdings & Advisory, LLC. | 3,714,020 |
Reported balance
Holding disclosure · report date 2025-03-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,714,020 F2: Reporting Person is the sole member and manager of AFH Holding & Advisory, LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy KIG LLC. | 550,000 |
Reported balance
Holding disclosure · report date 2025-03-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 550,000 F3: Such shares are held by KIG LLC of which Reporting Person's spouse is the sole member. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein. |
| Common StockSEC Table I · non-derivative | IndirectBy HCWG LLC. | 220,454 |
Reported balance
Holding disclosure · report date 2025-03-25 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 220,454 F4: Such shares represent only Reporting Person's percentage interest in HCWG LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes (i) 500,000 shares held by certain members of Reporting Person's immediate family of which Reporting Person disclaims beneficial ownership, except to the extent of his pecuniary interest, if any, therein, and (ii) 1,200,000 shares of restricted stock (the "Shares") granted pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest on a date that is seven months after the effective date of Issuer's initial listing.
F2: Reporting Person is the sole member and manager of AFH Holding & Advisory, LLC.
F3: Such shares are held by KIG LLC of which Reporting Person's spouse is the sole member. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
F4: Such shares represent only Reporting Person's percentage interest in HCWG LLC.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AFH Acquisition IX, Inc.
Report date August 30, 2017 · Filed September 19, 2017
Jointly reported with Heshmatpour Amir F
Section 16 reporting ended · disclosed 2017-09-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy AFH Holding & Advisory, LLC | 0 |
Reported balance
After 2017-08-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-08-30 · Other · Disposed 5,000,000 · Balance 0 F1: AFH Holding & Advisory LLC ("AFH Holding") owned the reported securities of the issuer directly. Mr. Heshmatpour, as the sole economic member and managing director of AFH Holding, had sole voting and investment power over the shares held by AFH Holding and may be deemed to have had an indirect interest in the reporting securities. |
Filing footnotes · ownership attribution and instrument terms
F1: AFH Holding & Advisory LLC ("AFH Holding") owned the reported securities of the issuer directly. Mr. Heshmatpour, as the sole economic member and managing director of AFH Holding, had sole voting and investment power over the shares held by AFH Holding and may be deemed to have had an indirect interest in the reporting securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2017 Filed Dec 5, 2017 21:20 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherCommon Stock | 915,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-007141 · s108359_form4.xml · nonDerivative · entry 4 Heshmatpour Amir F · CIK 0001443035 · 10% owner AFH Holding & Advisory, LLC · CIK 0001414636 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By H&H Funding, LLC Disclosed balance after: 2,942,393 F3 · ownership.direct: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein. Read SEC document |
| September 07, 2017 Filed Dec 5, 2017 21:20 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-007141 · s108359_form4.xml · nonDerivative · entry 3 Heshmatpour Amir F · CIK 0001443035 · 10% owner AFH Holding & Advisory, LLC · CIK 0001414636 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By H&H Funding, LLC Disclosed balance after: 2,026,779 F4 · kind: The reported shares reflect the transfer of securities held directly by H&H (Hong Kong) Holdings Co, of which Mr. Heshmatpour is the sole stockholder, to H&H. F2 · ownership.direct: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding. F3 · ownership.direct: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein. Read SEC document |
| September 07, 2017 Filed Dec 5, 2017 21:20 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherCommon Stock | 1,826,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-007141 · s108359_form4.xml · nonDerivative · entry 2 Heshmatpour Amir F · CIK 0001443035 · 10% owner AFH Holding & Advisory, LLC · CIK 0001414636 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By H&H Funding, LLC Disclosed balance after: 1,826,779 F1 · kind: The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC ("AFH Holding") to H&H Funding, LLC ("H&H"). F2 · ownership.direct: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding. F3 · ownership.direct: AFH Holding beneficially owns 80% of H&H's capital and may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour, as the sole member and managing director of AFH Holding, may be deemed to beneficially own the shares held by H&H. Mr. Heshmatpour and AFH Holding disclaim beneficial ownership of the shares owned by H&H except to the extent of their respective pecuniary interests therein. Read SEC document |
| September 07, 2017 Filed Dec 5, 2017 21:20 UTC | Bone Biologics Corp BBLG · Entity 8560 | OtherCommon Stock | 1,826,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-007141 · s108359_form4.xml · nonDerivative · entry 1 Heshmatpour Amir F · CIK 0001443035 · 10% owner AFH Holding & Advisory, LLC · CIK 0001414636 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AFH Holding & Advisory LLC Disclosed balance after: 1,941,579 F1 · kind: The reported shares reflect the transfer of shares held directly by AFH Holding & Advisory LLC ("AFH Holding") to H&H Funding, LLC ("H&H"). F2 · ownership.direct: Amir Farrokh Heshmatpour is the sole member and managing director of AFH Holding and has sole voting and investment power over the shares held by AFH Holding and may be deemed to beneficially own the shares held by AFH Holding. Read SEC document |
| August 30, 2017 Filed Sep 19, 2017 20:21 UTC | AFH Acquisition IX, Inc. NONE · Entity 173075 | OtherCommon Stock | 5,000,000 | $0.15 | $750,000.00 |
DisclosureSEC source: 0001615774-17-005208 · s107552_form4.xml · nonDerivative · entry 1 Heshmatpour Amir F · CIK 0001443035 · Director · President and Secretary · 10% owner AFH Holding & Advisory, LLC · CIK 0001414636 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AFH Holding & Advisory, LLC Disclosed balance after: 0 F1 · ownership.direct: AFH Holding & Advisory LLC ("AFH Holding") owned the reported securities of the issuer directly. Mr. Heshmatpour, as the sole economic member and managing director of AFH Holding, had sole voting and investment power over the shares held by AFH Holding and may be deemed to have had an indirect interest in the reporting securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.